Related Experiment Video
Updated: Aug 15, 2025

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
Protein sumoylation in normal and cancer stem cells
Qiuhong Zhu1, Panpan Liang1, Cuiying Chu1
1Intelligent Pathology Institute, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Protein sumoylation, a key post-translational modification, is crucial for maintaining stemness in both normal and cancer stem cells. Targeting sumoylation offers potential therapeutic strategies for diseases involving stem cells.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Stem cells possess self-renewal and differentiation capabilities, vital in tissue homeostasis and cancer.
- Cell stemness is regulated by complex molecular mechanisms, including reversible post-translational protein modifications (PTMs).
- Post-translational protein modifications are increasingly recognized for their role in acquiring and maintaining stemness.
Purpose of the Study:
- To review the functions of protein sumoylation in normal and cancer stem cells.
- To describe the regulators and effectors of sumoylation linked to cell stemness.
- To introduce therapeutic strategies targeting sumoylation for stem cell-related diseases.
Main Methods:
- Literature review of studies on protein sumoylation and stem cells.
- Analysis of upstream regulators and downstream effectors of sumoylation in stemness.
- Examination of translational studies and future research directions.
Main Results:
- Protein sumoylation is a critical PTM in stem cell populations during development and tumorigenesis.
- Sumoylation plays significant roles in various normal and cancer stem cell types.
- Specific upstream regulators and downstream effectors of sumoylation are associated with maintaining stemness.
Conclusions:
- Protein sumoylation is a key regulator of cell stemness with implications in normal development and cancer.
- Targeting sumoylation pathways presents a promising therapeutic avenue for diseases involving stem cells.
- Further research into sumoylation in stem cells is warranted to explore its full therapeutic potential.
Related Concept Videos
Abnormal Proliferation
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Induced Pluripotent Stem Cells
Somatic...
Epigenetic Regulation
X-chromosome...

